Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Biopharm Drug Dispos ; 2(2): 185-90, 1981.
Article in English | MEDLINE | ID: mdl-6113858

ABSTRACT

Fourteen normal male subjects were given either 60mg or 180mg of terfenadine suspension in a randomized two-way crossover study. Peak plasma concentrations of 1.544 +/- 0.726 (mean +/- S.D.) ng ml-1 were obtained in 0.786 h following the 60 mg dose and displayed an AUC or 11.864 +/- 3.369 ng h ml-1. Whereas peak plasma concentrations of 4.519 +/- 2.002 ng ml-1 in 1.071 +/- 0.514 h were obtained following the 180 mg dose. The AUC following the 180 mg dose was 44.341 +/- 22.041 ng h ml-1. When 60 mg of 14C terfenadine was given to six additional subjects, the peak plasma concentrations of 351 +/- 43 ng equivalents per ml were obtained in 1.67 +/- 0.41 h and the AUC was 2297.71 +/- 310.85 ng-equivalents h ml-1. This indicates that approximately 99.5 per cent of the terfenadine related material that is absorbed undergoes biotransformation. Urinary excretion of 14C accounted for 39.89 +/- 5.29 per cent of the dose while 60.58 +/- 2.44 per cent of the dose was recovered in the feces in twelve days. Thin-layer chromatographic (TLC) examination of fecal extracts showed only a trace of material chromatographing with terfenadine. This may indicate that the 14C present in the feces is not due to lack of absorption.


Subject(s)
Benzhydryl Compounds/metabolism , Histamine H1 Antagonists/metabolism , Piperidines/metabolism , Biological Availability , Humans , Kinetics , Male , Terfenadine
3.
J Int Med Res ; 4(6): 375-81, 1976.
Article in English | MEDLINE | ID: mdl-1027632

ABSTRACT

Since no practical animal model is available for the evaluation of compounds in vivo, we have developed an in vitro model for determining the effect of compounds on the rate of sickling of erythrocytes in whole blood taken from patients with sickle cell anaemia. RMI 6792 (a phenethanol-diamine derivative), procaine, and L-glutamine were tested in this in vitro system. RMI 6792 was tested at various concentrations in whole blood. The data indicate that RMI 6792 decreased the rate of sickling at and above 60 microgram/ml. Procaine slightly decreased sickling rate at 100 microgram/ml. L-glutamine at 555 had no inhibitory effect. RMI 6792 and procaine had no effect on the oxygen dissociation curve. RMI 6792 affected the calcium flux of the erythrocytes and the calcium concentration in the erythrocytes.


Subject(s)
Aniline Compounds/pharmacology , Antisickling Agents/pharmacology , Erythrocyte Membrane/drug effects , Erythrocytes/drug effects , Ethanolamines/pharmacology , Glutamine/pharmacology , Procaine/pharmacology , 2-Hydroxyphenethylamine/analogs & derivatives , Anemia, Sickle Cell/blood , Anemia, Sickle Cell/physiopathology , Calcium/blood , Erythrocytes/analysis , Humans , Methods , Oxygen/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...